Stay updated on COR388 for AD: Phase 2/3 Clinical Trial
Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page
- Check3 days agoChange DetectedThe Study Details page adds a comprehensive list of trial locations by state and country (Arizona, California, Florida, Georgia, Idaho, Illinois, Kansas, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Virginia, Washington, Wisconsin; Cedex; Gipuzkoa; Birmingham; London; Science Park; UK) and replaces older location blocks with an updated geography (Revision: v3.3.3).SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 is now shown, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check40 days agoChange DetectedThe government funding operating status notice for the NIH Clinical Center has been removed from the page. This affects only a site-wide banner and does not alter the study details.SummaryDifference0.2%

- Check54 days agoChange DetectedTwo screenshots of the Study Details page show no additions or deletions to core content; the content, sections, and navigation appear unchanged aside from minor visual formatting. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.